Skip to main content
SpringerPlus

Table 2 Adverse events after administration of gefinitib

From: Skin rash by gefitinib is a sign of favorable outcomes for patients of advanced lung adenocarcinoma in Japanese patients

(cases)

Total (%)

Skin rash

10 (41.7)

Liver damage

9 (37.5)

Diarrhea

4 (16.7)

Acute lung injury

2 (8.3)

Back to article page